ProCE Banner Activity

Initiating ART in Patients With Opportunistic Infections: Sooner Is Better

Clinical Thought
How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.

Released: December 13, 2021

Expiration: December 12, 2022

No longer available for credit.

Share

Faculty

Cristina Mussini

Cristina Mussini, MD

Full Professor of Infectious Diseases
Chief of the Clinic of Infectious Diseases, University Hospital of Modena
University of Modena and Reggio Emilia
Modena, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Cristina Mussini, MD

Full Professor of Infectious Diseases
Chief of the Clinic of Infectious Diseases, University Hospital of Modena
University of Modena and Reggio Emilia
Modena, Italy

Cristina Mussini, MD, has disclosed that she has received consulting fees from AbbVie, Angelini Pharma, Gilead Sciences, Janssen, MSD, and ViiV Healthcare and funds for research support from Gilead Sciences, Janssen, MSD, and ViiV Healthcare.

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.